Deliver Your News to the World

$2 Billion U.S. Autism Treatment Market is Poised for Growth Next Year

Insurance Coverage Grows, New Programs Emerge

New Market Study
New Market Study

"Awareness of autism treatment programs is growing."

Dec. 15, 2020 - Marketdata LLC, a 41-year old market research and consulting firm specializing in the tracking of service and healthcare sectors, has released a new 57-page study: “The U.S. Market for Autism Treatment Programs”. The study analyzes the nature of Applied Behavior Analysis (ABA) and other programs and the for-profit and non-profit treatment centers providing them, patient demographics, treatment center revenues, rankings and key metrics, the autism medications market, and more. Industry size tracked from 2009 to 2025 Forecasts, including the effects of the Covid-19 pandemic.

“There are 3.5 million children and adults with autism in America. The North American market for autism disorder and treatment is expected to grow over the next five years, due to a variety of factors: more widespread awareness of the condition, efforts by advocacy groups, an increase in the number of ABA (Applied Behavior Analysis) treatment programs and centers, more insurance coverage, and new and more effective drugs for the treatment of autistic patients.”, according to John LaRosa, Research Director.

Major Findings:

* Market Value & Growth…  This is a market valued at $2.0 billion in 2020 that is forecast to grow 4.0% per year to $2.45 billion by 2025. The pandemic did result in a shift to more telehealth services. Treatment programs generated $1.4 billion in 2019, while the medications market was worth $627 million.

* Treatment center revenues… are expected to grow 4.5% per year from 2021 to 2025, outpacing the growth of the autism drugs market, which is forecast to grow 3.0% per year (average annual rate).
* The number of autistic children is rising in the United States, at the rate of 6.2% per year. The CDC now estimates that 1 in 54 children born in the U.S. are autistic.
* More Treatment Centers…. The overwhelming majority of the largest for-profit treatment companies has increased the number of centers they operate, and their revenues, compared to 2017.
* The Autism Drugs Market… Several medications (Risperdal, Concerta) are still used to treat people with autism, and less costly generics have entered the market, resulting in lower total revenues. There is substantial R&D taking place to develop new and more effective drugs.
* Insurance coverage… of autistic children has improved over the past four years, with 64% now covered (vs. 36% in 2016). All 50 states now cover it.
* The top 9 for-profit chains… are estimated to have posted 2019 revenues of $547 million.

About The Report

This is a detailed and current analysis entitled: The U.S. Market for Autism Treatment Programs, published in Dec. 2020. The analysis is 57 pages long, with 11 in-depth competitor/treatment center chain profiles. The report’s price is $995, and it may be purchased at: (report FS 62). There is also a 17-page Overview Summary report for $99 (Report OV 65). A complete Table of Contents and description are found on the Marketdata website (Services tab, then choose Studies).

About Marketdata

Marketdata is an independent market research publisher and consulting firm that specializes in service sectors, helathcare markets, and niche emerging markets. It publishes multi-client, off-the-shelf studies, performs custom research projects, and offers teleconferences with its analysts.

( Press Release Image: )


 Autism Spectrum Disorder
 Industry Reports
 Autism Treatment
 Aba Therapy
 Autism Drugs

This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.